Editas Medicine Inc. (EDIT)
NASDAQ · Healthcare
Editas Medicine Inc. Shareholder Equity 2016–2025
Editas Medicine Inc. annual shareholder equity history from 2016 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Editas Medicine Inc. shareholder equity as of December 31, 2025: 27.3M, a 79.68% decrease year-over-year.
- Editas Medicine Inc. shareholder equity for 2025 were 27.3M, a 79.68% decrease from 2024.
- Editas Medicine Inc. shareholder equity for 2024 were 134.3M, a 61.54% decrease from 2023.
- Editas Medicine Inc. shareholder equity for 2023 were 349.1M, a 3.21% decrease from 2022.
- Editas Medicine Inc. shareholder equity for 2022 were 360.7M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Editas Medicine Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $27 |
| 2024 | $134 |
| 2023 | $349 |
| 2022 | $361 |
| 2021 | $554 |
| 2020 | $394 |
| 2019 | $262 |
| 2018 | $236 |
| 2017 | $208 |
| 2016 | $135 |
Editas Medicine Inc. Shareholder Equity — FAQ
Editas Medicine Inc. (EDIT) shareholder equity over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see EDIT's shareholder equity history?
The chart and table above show Editas Medicine Inc.'s shareholder equity by year and by quarter, including the growth rate.